1. AHRO : Austin Health Research Online

Alexander Dobrovic

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Alexander Dobrovic
Full Name
Dobrovic, Alexander
 
Department
 
ORCID
Twitter
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Kondrashova, Olga

Results 1-6 of 6 (Search time: 0.012 seconds).

Publication YearTitleAuthor(s)
12024The role of aberrant DNA methylation in cancer initiation and clinical impacts.Geissler, Franziska; Nesic, Ksenija; Kondrashova, Olga; Dobrovic, Alexander ; Swisher, Elizabeth M; Scott, Clare L; J Wakefield, Matthew
22023The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models.Ho, Gwo Yaw; Vandenberg, Cassandra J; Lim, Ratana; Christie, Elizabeth L; Garsed, Dale W; Lieschke, Elizabeth; Nesic, Ksenija; Kondrashova, Olga; Ratnayake, Gayanie; Radke, Marc; Penington, Jocelyn S; Carmagnac, Amandine; Heong, Valerie; Kyran, Elizabeth L; Zhang, Fan; Traficante, Nadia; Huang, Ruby; Dobrovic, Alexander ; Swisher, Elizabeth M; McNally, Orla; Kee, Damien ; Wakefield, Matthew J; Papenfuss, Anthony T; Bowtell, David D L; Barker, Holly E; Scott, Clare L
315-Sep-2021Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma.Nesic, Ksenija; Kondrashova, Olga; Hurley, Rachel M; McGehee, Cordelia D; Vandenberg, Cassandra J; Ho, Gwo-Yaw; Lieschke, Elizabeth; Dall, Genevieve; Bound, Nirashaa; Shield-Artin, Kristy; Radke, Marc; Musafer, Ashan; Chai, Zi Qing; Ghamsari, Mohammad Reza Eftekhariyan; Harrell, Maria I; Kee, Damien ; Olesen, Inger; McNally, Orla; Traficante, Nadia; Australian Ovarian Cancer Study, null; DeFazio, Anna; Bowtell, David D L; Swisher, Elizabeth M; Weroha, S John; Nones, Katia; Waddell, Nicola; Kaufmann, Scott H; Dobrovic, Alexander ; Wakefield, Matthew J; Scott, Clare L
4Sep-2021Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance.Hurley, Rachel M; McGehee, Cordelia D; Nesic, Ksenija; Correia, Cristina; Weiskittel, Taylor M; Kelly, Rebecca L; Venkatachalam, Annapoorna; Hou, Xiaonan; Pathoulas, Nicholas M; Meng, X Wei; Kondrashova, Olga; Radke, Marc R; Schneider, Paula A; Flatten, Karen S; Peterson, Kevin L; Becker, Marc A; Wong, Ee Ming; Southey, Melissa S; Dobrovic, Alexander ; Lin, Kevin K; Harding, Thomas C; McNeish, Iain; Ross, Christian A; Wagner, Jill M; Wakefield, Matthew J; Scott, Clare L; Haluska, Paul; Wahner Hendrickson, Andrea E; Karnitz, Larry M; Swisher, Elizabeth M; Li, Hu; Weroha, S John; Kaufmann, Scott H
528-Jul-2021Acquired RAD51C promoter methylation loss causes PARP inhibitor resistance in high grade serous ovarian carcinoma.Nesic, Ksenija; Kondrashova, Olga; Hurley, Rachel M; McGehee, Cordelia D; Vandenberg, Cassandra J; Ho, Gwo-Yaw; Lieschke, Elizabeth; Dall, Genevieve; Bound, Nirashaa; Shield-Artin, Kristy; Radke, Marc; Musafer, Ashan; Chai, Zi Qing; Eftekhariyan Ghamsari, Mohammad Reza; Harrell, Maria I; Kee, Damien ; Olesen, Inger; McNally, Orla; Traficante, Nadia; Cancer Study, Australian Ovarian; DeFazio, Anna; Bowtell, David D L; Swisher, Elizabeth M; Weroha, S John; Nones, Katia; Waddell, Nicola; Kaufmann, Scott H; Dobrovic, Alexander ; Wakefield, Matthew J; Scott, Clare L
628-Sep-2018Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma.Kondrashova, Olga; Topp, Monique; Nesic, Ksenija; Lieschke, Elizabeth; Ho, Gwo-Yaw; Harrell, Maria I; Zapparoli, Giada V; Hadley, Alison; Holian, Robert; Boehm, Emma; Heong, Valerie; Sanij, Elaine; Pearson, Richard B; Krais, John J; Johnson, Neil; McNally, Orla; Ananda, Sumitra; Alsop, Kathryn; Hutt, Karla J; Kaufmann, Scott H; Lin, Kevin K; Harding, Thomas C; Traficante, Nadia; deFazio, Anna; McNeish, Iain A; Bowtell, David D; Swisher, Elizabeth M; Dobrovic, Alexander ; Wakefield, Matthew J; Scott, Clare L